Morphoimmunohistochemical differential diagnostics of "grey zone" large lymphomas.

被引：0
|
作者：
不详
机构：
来源：
VIRCHOWS ARCHIV | 2005年 / 447卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：262 / 263
页数：2
相关论文
共 50 条
  • [31] Prognostic significance of CD5 expression in diffuse large B-cell lymphomas.
    Yamaguchi, M
    Seto, M
    Morishima, Y
    Ichinohasama, R
    Okamoto, M
    Nakamura, N
    Yoshino, T
    Suzumiya, J
    Ueda, R
    Nakamura, S
    BLOOD, 2000, 96 (11) : 506A - 506A
  • [32] Cytokines and cytokine receptors pattern in primary cutaneous CD30+ large cells lymphomas.
    Tomasini, D
    Ceni, A
    Venegoni, L
    Gentili, E
    Caputo, R
    Berti, E
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (03) : 320 - 320
  • [33] Molecular characterisation of 7q translocations in splenic lymphoma with villous lymphocytes/splenic marginal zone lymphomas.
    Gruszka-Westwood, A
    Callet-Bochu, E
    Radford-Weiss, I
    Matutes, E
    Catovsky, D
    Coignet, LJA
    BLOOD, 1998, 92 (10) : 224B - 224B
  • [34] The incidence of API2-MLT fusion transcripts among extranodal, nodal, and splenic marginal zone lymphomas.
    Remstein, ED
    James, CD
    Kurtin, PJ
    BLOOD, 1999, 94 (10) : 384A - 384A
  • [35] Analysis of CD95/FAS gene somatic mutations in marginal zone B-cell lymphomas.
    Bertoni, F
    Conconi, A
    Luminari, S
    Realini, C
    Roggero, E
    Baldini, L
    Carobbio, S
    Neri, A
    Cavalli, F
    Zucca, E
    BLOOD, 1999, 94 (10) : 242B - 242B
  • [36] Differential expression of CCR1 and CCR5 in B cell and T cell lymphomas.
    Mazur, GG
    Kryczek, II
    Krzysiek, RR
    Kuliczkowski, KK
    Lange, AA
    BLOOD, 2001, 98 (11) : 231B - 231B
  • [37] Clinicopathologic Significance of Increased Large Cells in Marginal Zone Lymphomas
    Stonhill, Miekan
    Louissaint, Abner
    Sohani, Aliyah
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1241 - S1242
  • [38] CDNA microarray analysis of genes associated with NPM-ALK overexpression in anaplastic large cell lymphomas.
    Lim, MS
    Fillmore, GC
    Jenson, SD
    Friedman, RA
    Schumacher, JA
    Perkins, SL
    Rassidakis, GZ
    Medeiros, LJ
    Cairo, MS
    Elenitoba-Johnson, KSJ
    BLOOD, 2004, 104 (11) : 625A - 625A
  • [39] TREATMENT AND CLINICAL RESULTS IN PATIENTS >70 YEARS WITH DIFFUSED LARGE CELL B LYMPHOMAS. EXPERIENCE IN A CENTRE
    Roldan Perez, A.
    Masso Asensio, P.
    Herraez Garcia, R.
    Gimenez Mesa, E.
    Vazquez Paganini, J. A.
    Cordoba Mascunano, R.
    Mora Casado, A.
    HAEMATOLOGICA, 2015, 100 : 159 - 159
  • [40] Common and differential chemokine expression patterns in RS cells of NLP, EBV positive and negative classical Hodgkin lymphomas.
    Maggio, EM
    van den Berg, A
    Visser, L
    Diepstra, A
    Emmens, R
    Poppema, S
    BLOOD, 2001, 98 (11) : 598A - 598A
12345